C
CRISPR Therapeutics AG (CRSP)
NGM – Real vaqt narxi. Valyuta: USD
52.83
-1.18 (-2.18%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
52.83
-1.18 (-2.18%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Daromad taqsimoti ma'lumotlari hali hisoblanmagan.
No Data
Ushbu aksiya uchun yangiliklar yo'q.
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 17.96 | 6.05 | 10 | |
| Tezkor likvidlik nisbati | 17.96 | 5.63 | 10 | |
| Qarz/Kapital nisbati | 0.43 | 0.30 | 7.0 | |
| Qarz/Aktivlar nisbati | 0.29 | 1.04 | 7.0 | |
| Foiz to‘lov qoplami | N/A | -16.91 | 1.0 | |
| O‘rtacha ball | 7.0 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 1M | 371M | 37M | 4M | 4M |
| Yalpi foyda | -133M | 221M | -92M | -229M | -217M |
| Operatsion daromad | -673M | -223M | -467M | -568M | -550M |
| Sof foyda | -650M | -154M | -366M | -582M | -569M |
| EBITDA | -649M | -203M | -447M | -549M | -531M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | 697.54 | 51.34 | 10 |
| Keyingi chorak | 1553.59 | 0.44 | 6.0 |
| Joriy yil | 1182.24 | 25.26 | 10 |
| Keyingi yil | 205.93 | 20.98 | 10 |
| O‘rtacha ball | 9.0 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 68.75 | 5.88 | 6.57 | -17.54 | 5.3 |
| Yil/Yil | 68.55 | 9.61 | 18.99 | -102.01 | 6.5 |
| 3 yil o‘rtacha | 10234.99 | -40.27 | -31.98 | -14.44 | 3.3 |
| 5 yil o‘rtacha | 31552.01 | -36.94 | -36.99 | 3.65 | 4.0 |
| O‘rtacha ball | 4.8 | ||||
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |
Umumiy qarz $787.6M naqd pul zahiralaridan ($423.7M) sezilarli darajada ko'p bo'lib, moliyaviy barqarorlik xavotirlarini keltirib chiqaradi
Jami joriy aktivlar $2.4B jami joriy majburiyatlardan $136.3M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (0.4) tarmoq o'rtachasidan (0.3) sezilarli past bo'lib, ehtiyotkor moliyaviy boshqaruvni namoyish etadi
Foiz xarajatlari mavjud, ammo EBIT ma'lumotlari mavjud emas, bu potentsial rentabellik muammolarini ko'rsatadi
Salbiy erkin pul oqimi -$109.4M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi